New Aveeno Report Reveals 71% of Adults Have Sensitive Skin
The Aveeno brand has launched its first-ever State of Skin Sensitivity Report, which examines the causes of sensitive skin, and explores the connection between body, mind, and skin. While body positivity has spread to mainstream culture in recent years, self-love can be challenging for those of us with sensitive skin. The Aveeno report shows that 71% of adults identify as having sensitive skin, an astounding increase of 55% in 2 decades. The impact of this sensitivity is more than skin deep, as common skin conditions can carry significant psychological impact, influencing quality of life and emotional well-being.
Research from the State of Skin Sensitivity report validates the relationship between emotions and perceptions of sensitive skin.
- Skin is both a receiver and a reactor to sensory stimuli, meaning that everything from the environment to skin products can show up in our pores and negatively influence emotions.
- One-third of patients with skin diseases like acne, atopic dermatitis, psoriasis, and rosacea are estimated to struggle with emotional disorders, including anxiety and depression.
- 50% of adults with moderate to severe atopic dermatitis reported that it puts a damper on their social functions, sleep, work productivity, leisure activities, and family relationships.
- Aveeno recognizes the broad issue of sensitivity as a skin state, rather than a clinical diagnosis and seeks to shine a light on its prevalence, as well as possible areas of prevention.
"Treating patients goes well beyond simply analyzing their skin. It's about how their skin impacts their overall emotional well-being, which is something I consistently see with my patients," says Dr. Mara Weinstein Velez, Board Certified Dermatologist and paid Aveeno consultant, in a news release. "The mind-skin connection is a powerful one, and the Aveeno brand's ability to assemble this in-depth report examining the impact of skin sensitivity provides much needed visibility for the dermatology community."
"Our brand heritage is built on leadership and expertise in the sensitive skin state, and this report illustrates the meaningful impact sensitive skin has on people's lives," says KC Hagin, Commercial Leader for Aveeno at Johnson & Johnson Consumer Inc. "We have an obligation not only to provide product solutions but to help de-stigmatize the word 'sensitive' and to turn a common struggle into a strength. Aveeno wants to be front and center of the conversation and is encouraging everyone to be proud of their sensitive skin."
To further encourage conversation around what it really means to have sensitive skin, Aveeno is calling on consumers to share their #ProudlySensitiveSkin stories on social media. The campaign aims to highlight various consumer experiences with skin conditions and showcase how people have learned to love their sensitive skin. By changing the narrative, Aveeno is facilitating connection with like-minded individuals in a deeper way and celebrating sensitive skin, and all that comes with it.
All submissions will be entered for the chance to win a virtual mentoring session with one brand partner, Tia Mowry or Hyram Yarbro.
To enter:
- Share your #ProudlySensitiveSkin story on Instagram or TikTok
- Tag @AveenoUS and the hashtags #ProudlySensitiveSkin #Sweepstakes
- Contest closes on December 15, 2022
Aveeno knows that sensitive skin is real and can have a tremendous impact on quality of life which is strongly illustrated in this report. The brand is committed to igniting and fueling the positive narrative around sensitive skin, while also being dedicated to delivering products that bring nourishing solutions to sensitive skin.
Forty-one Aveeno products carry the "Trusted Choice" SkinSAFE Seal which uses over 25 years of clinical skin testing data to help people with sensitive skin find the right products that are safe for their skin. Aveeno is committed to being transparent with consumers about the products they use every day and how it affects their skin, their health and the planet.